- Home
- QBTS vs ZLAB Comparison
QBTS vs ZLAB Comparison
Compare QBTS & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QBTS
- ZLAB
- Stock Information
- Founded
- QBTS 1999
- ZLAB 2013
- Country
- QBTS United States
- ZLAB China
- Employees
- QBTS N/A
- ZLAB N/A
- Industry
- QBTS Retail: Computer Software & Peripheral Equipment
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- QBTS Technology
- ZLAB Health Care
- Exchange
- QBTS Nasdaq
- ZLAB Nasdaq
- Market Cap
- QBTS 5.3B
- ZLAB 4.3B
- IPO Year
- QBTS N/A
- ZLAB 2017
- Fundamental
- Price
- QBTS $16.88
- ZLAB $34.96
- Analyst Decision
- QBTS Strong Buy
- ZLAB Buy
- Analyst Count
- QBTS 10
- ZLAB 5
- Target Price
- QBTS $19.40
- ZLAB $54.28
- AVG Volume (30 Days)
- QBTS 47.9M
- ZLAB 860.8K
- Earning Date
- QBTS 08-07-2025
- ZLAB 08-07-2025
- Dividend Yield
- QBTS N/A
- ZLAB N/A
- EPS Growth
- QBTS N/A
- ZLAB N/A
- EPS
- QBTS N/A
- ZLAB N/A
- Revenue
- QBTS $22,275,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- QBTS $180.44
- ZLAB $45.16
- Revenue Next Year
- QBTS $56.52
- ZLAB $56.81
- P/E Ratio
- QBTS N/A
- ZLAB N/A
- Revenue Growth
- QBTS 120.20
- ZLAB 32.56
- 52 Week Low
- QBTS $0.75
- ZLAB $16.01
- 52 Week High
- QBTS $20.56
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- QBTS 48.52
- ZLAB 45.24
- Support Level
- QBTS $16.56
- ZLAB $33.17
- Resistance Level
- QBTS $19.17
- ZLAB $39.64
- Average True Range (ATR)
- QBTS 1.42
- ZLAB 1.19
- MACD
- QBTS -0.22
- ZLAB -0.31
- Stochastic Oscillator
- QBTS 17.67
- ZLAB 22.29
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.